Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Miltefosine Promotes Neutrophil Differentiation via Ras/MEK/
2026-06-15
A recent study reveals that Miltefosine, best known as a PI3K/Akt pathway inhibitor, also activates the Ras/MEK/ERK cascade to promote neutrophil differentiation and restore bone marrow function in leukopenia models. These mechanistic insights offer new translational opportunities for hematology research and therapeutic strategy development.
-
Z-IETD-FMK: Applied Caspase-8 Inhibition for Apoptosis Studi
2026-06-15
Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) delivers targeted caspase-8 inhibition, empowering researchers to dissect apoptosis and immune signaling with unmatched precision. This guide translates recent breakthroughs and protocol innovations into practical steps and troubleshooting strategies for advanced cell death and immune activation assays.
-
Masitinib (AB1010): Practical Guidance for KIT/PDGFR Researc
2026-06-14
Masitinib (AB1010) is a selective phenylaminothiazole-type tyrosine kinase inhibitor designed for research targeting KIT, PDGFRα, and PDGFRβ pathways, particularly in cancer biology, mastocytosis, and inflammatory disease models. It is optimal for DMSO-based workflows requiring precise kinase inhibition and should not be used in protocols demanding broad-spectrum inhibition or aqueous/ethanol solubility.
-
Estradiol in Research: Protocols, Innovations, and Troublesh
2026-06-13
Estradiol (17 beta-estradiol) from APExBIO empowers advanced research on estrogen receptor signaling and organ protection, offering precision in modeling complex physiological pathways. This guide details protocol enhancements, troubleshooting strategies, and the latest mechanistic insights for maximizing experimental success.
-
L. gasseri ATCC33323 Modulates Colitis via NR1I3-E-cadherin
2026-06-12
Qian et al. demonstrate that Lactobacillus gasseri ATCC33323 significantly ameliorates DSS-induced colitis in mice by preserving intestinal barrier integrity through NR1I3-mediated upregulation of E-cadherin. This mechanistic insight advances the understanding of probiotic action in IBD and highlights E-cadherin as a key therapeutic target.
-
Tamoxifen’s Immunomodulatory Mechanisms: Expanding SERM Util
2026-06-12
Explore how Tamoxifen, a selective estrogen receptor modulator, drives immunomodulation and radiosensitization in cancer research. This article reveals new mechanistic insights and practical protocols, going beyond standard SERM applications.
-
AO/PI Staining Solution: Precision Fluorescent Cell Counting
2026-06-11
AO/PI Staining Solution redefines fluorescent cell viability assays with unmatched accuracy in live/dead cell discrimination, even in complex samples. Its dual fluorescent DNA dye system enables reliable, debris-resistant quantification and supports advanced research into inflammation and apoptosis.
-
Sulfo-NHS-SS-Biotin: Reversible Cell Surface Protein Labelin
2026-06-11
Unlock precise, reversible biotinylation of cell surface proteins with the Sulfo-NHS-SS-Biotin Kit. Its unique disulfide-cleavable linker empowers selective workflow control for proteomics, interactome mapping, and dynamic cell surface studies—far beyond conventional biotinylation reagents.
-
O-GlcNAcylation Orchestrates Wnt-Induced Bone Formation via
2026-06-10
This study uncovers how Wnt3a-mediated O-GlcNAcylation, through both rapid and sustained pathways, is indispensable for osteoblast-driven bone formation by rewiring aerobic glycolysis. The findings highlight a novel metabolic and post-translational axis, offering mechanistic insight into bone anabolism and potential new targets for osteoporosis research.
-
Tetracycline: Mechanistic Insights and Assay Design in Micro
2026-06-10
Discover the multifaceted role of tetracycline, a broad-spectrum polyketide antibiotic, in advancing microbiological assay design and ribosomal research. This article uniquely bridges molecular mechanism, protocol optimization, and recent telomerase regulation breakthroughs to inform experimental strategies.
-
3-Methyladenine in Autophagy Research: Protocols & Insights
2026-06-09
3-Methyladenine (3-MA) stands apart as a precision autophagy inhibitor, enabling nuanced dissection of phosphoinositide 3-kinase signaling in cancer and virology. This guide translates experimental best practices, new mechanistic findings, and troubleshooting tips into actionable workflows for advanced research.
-
Dihydroartemisinin: Advanced Workflows for Malaria and mTOR
2026-06-09
Dihydroartemisinin, a potent Artemisia plant extract, delivers high-impact utility in malaria modeling and mTOR pathway inhibition. This guide demystifies experimental workflows, protocol enhancements, and troubleshooting tactics for extracting maximum value from APExBIO’s high-purity dihydroartemisinin in translational research.
-
BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lipid
2026-06-08
BODIPY 581/591 C11 stands out as a robust, ratiometric fluorescent probe for precise, quantitative lipid peroxidation detection in live cells and membranes. Its unique red-to-green spectral shift, high photostability, and selectivity for oxygen radicals streamline workflows and empower advanced oxidative stress research across cardiovascular, neurodegenerative, and ferroptosis studies.
-
Bacitracin (B1670): Technical Guidance for Antibacterial Res
2026-06-08
Bacitracin is a peptide antibiotic designed for laboratory workflows investigating bacterial cell wall and peptidoglycan synthesis disruption. It is suitable for controlled antibacterial research targeting both gram-positive and gram-negative bacteria, but should not be used for diagnostic or medical purposes.
-
Q-VD-OPh: Pan-Caspase Inhibitor Empowering Apoptosis Researc
2026-06-07
Q-VD-OPh stands out as a potent, cell-permeable pan-caspase inhibitor driving precision in apoptosis research and neurodegeneration studies. This article details advanced workflows, actionable troubleshooting, and the latest mechanistic insights, linking foundational protocol optimization with cutting-edge virology and disease models.